Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone
Standard
Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone. / Karagiannis, Panagiotis; Alsdorf, Winfried; Tallarek, Ann-Christin; Blohm, Martin E; Oelrich, Jennyfer; Waizenegger, Jonas S; Wolschke, Christine; Hecher, Kurt; Singer, Dominique; Bokemeyer, Carsten; Fiedler, Walter.
in: BRIT J HAEMATOL, Jahrgang 192, Nr. 2, 01.2021, S. e60-e63.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high-dose cytarabine and mitoxantrone
AU - Karagiannis, Panagiotis
AU - Alsdorf, Winfried
AU - Tallarek, Ann-Christin
AU - Blohm, Martin E
AU - Oelrich, Jennyfer
AU - Waizenegger, Jonas S
AU - Wolschke, Christine
AU - Hecher, Kurt
AU - Singer, Dominique
AU - Bokemeyer, Carsten
AU - Fiedler, Walter
N1 - Correspondence
PY - 2021/1
Y1 - 2021/1
U2 - 10.1111/bjh.17220
DO - 10.1111/bjh.17220
M3 - Other (editorial matter etc.)
C2 - 33222152
VL - 192
SP - e60-e63
JO - BRIT J HAEMATOL
JF - BRIT J HAEMATOL
SN - 0007-1048
IS - 2
ER -